Exactly 100 years ago, famed Austrian physicist Erwin Schrödinger (yes, the cat guy) postulated his eponymous equation that explains how particles in quantum physics behave. A key component of quantum mechanics, Schrödinger’s Equation provides a way to calculate the wave function of a system and how it changes dynamically inContinue Reading
Goldman Sachs (NYSE:GS) has lodged an appeal with the U.S. Federal Reserve challenging the regulator’s most recent “stress test”, which is set to force the bank to hold a greater amount of capital, the Financial Times reported on Sunday, citing people familiar with the matter. The Fed’s stress test determinesContinue Reading
Parradee Kietsirikul Uber Technologies (NYSE:UBER) and Lyft (NASDAQ:LYFT) traded lower on Wednesday after the labor-backed Drivers Demand Justice coalition filed the final batch of voter signatures needed to place its unionization push on the November ballot for Massachusetts voters. A vote in Massachusetts on ride-hailing worker unionization would be theContinue Reading
moxiecreative Ahead of the CEO Investor Summit, Aehr Test Systems (NASDAQ:AEHR) stock was up 14.3% in premarket trade on Wednesday after it reported preliminary financial results for its fourth quarter and fiscal year 2024 and said that its FY24 revenue and net income exceed its previously provided guidance. For itsContinue Reading
da-kuk/E+ via Getty Images Sales growth for AI-related megacap stocks is expected to have cooled in Q2 and continue that trend through the end of the year. According to consensus forecasts, Nvidia (NASDAQ:NVDA), Microsoft (NASDAQ:MSFT), Meta (NASDAQ:META), Alphabet (NASDAQ:GOOG) (NASDAQ:GOOGL) and Amazon (NASDAQ:AMZN) will see a slowdown in sales growth,Continue Reading
U.Today – took a massive hit after reaching the $71,000 threshold, losing 14% of its value and plummeting below $60,000. However, there is a realistic possibility of a reversal in the foreseeable future as BTC has reached the lower threshold of the sideways market channel. First of all, BTC’s priceContinue Reading
designer491/iStock via Getty Images The U.S. FDA has granted marketing authorization to the Xpert HCV test and GeneXpert Xpress System, the first-ever point-of-care test for hepatitis C, from Danaher (NYSE:DHR) subsidiary Cepheid. The test can be performed in places such as doctors’ offices, emergency departments, and urgent care clinics. TheContinue Reading
